On June 22, 2020 Helix BioPharma Corp. (TSX: HBP) ("Helix" or the "Company"), an immuno-oncology
company developing innovative drug candidates for the prevention and treatment of cancer, reported that it will be presenting at Proactive One2One Virtual Investor Forum on June 23, 2020 (Press release, Helix BioPharma, JUN 22, 2020, View Source [SID1234561306]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. Heman Chao, Chief Executive Officer of Helix is scheduled to present on Tuesday, June 23rd at approximately
1:20pm Eastern Time. The presentation will be webcast live on the conference event platform. You can access the
invitation and register to the Investor Forum with the following link:
View Source

About Proactive Investors
With offices in the US and in Canada, Proactive Investors enables companies and investors to connect. The group
is one of the fastest growing financial media portals in the world, providing breaking news, commentary and analysis
on hundreds of listed companies and pre-IPO businesses across the globe on a 24/7 basis. For more information:
View Source